Association between inflammatory markers in induced sputum and clinical characteristics in children with non-cystic fibrosis bronchiectasis

Pediatric Pulmonology

Volumn 42, Issue 4, 2007, Pages 362-369

  Guran, Tulay ^a,c   Ersu, Refika ^a   Karadag, Bulent ^a   Akpinar, Ihsan Nuri ^a   Demirel, Gulderen Yanikkaya ^b   Hekim, Nezih ^b   Dagli, Elif ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b Dr Pakize i Tarzi Laboratuarlari Turkey   (Turkey)

^c Pakize Tarzi Laboratories ^*  (Turkey)

Author keywords

Bronchiectasis; Children; HRCT; IL 8; Induced sputum; TNF

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; BRONCHIECTASIS; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FORCED EXPIRATORY VOLUME; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INFLAMMATION; MALE; NEUTROPHIL; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; SPUTUM ANALYSIS; VITAL CAPACITY;

ADOLESCENT; BIOLOGICAL MARKERS; BRONCHIECTASIS; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-8; MALE; NEUTROPHILS; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SPUTUM; TOMOGRAPHY, X-RAY COMPUTED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34247238350     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20587     Document Type: Article

References (45)

1. Barker AF, Bardana EJ, Jr. Bronchiectasis: Update of an orphan disease. Am Rev Respir Dis 1988;137:969-978.
2. Karadag B, Karakoc F, Ersu R, Kut A, Bakac S, Dagli E. Non-cystic-fibrosis bronchiectasis in children: A persisting problem in developing countries. Respiration 2005;72:233-238.
3. Twiss J, Metcalfe R, Edwards E, Byrnes C. New Zealand national incidence of bronchiectasis "too high" for a developed country. Arch Dis Child 2005;90:737-740.
4. Nicotra MB, Rivera M, Dale AM, Shepherd R, Carter R. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest 1995;108:955-961.
5. Callahan CW, Redding GJ. Bronchiectasis in children: Orphan disease or persistent problem? Pediatr Pulmonol 2002;33:492-496.
6. Karakoc GB, Yilmaz M, Altintas DU, Kendirli SG. Bronchiectasis: Still a problem. Pediatr Pulmonol 2001;32:175-178.
7. Edwards EA, Metcalfe R, Milne DG, Thompson J, Byrnes CA. Retrospective review of children presenting with non cystic fibrosis bronchiectasis: HRCT features and clinical relationships. Pediatr Pulmonol 2003;36:87-93.
8. Dakin CJ, Pereira JK, Henry RL, Wang H, Morton JR. Relationship between sputum inflammatory markers, lung function, and lung pathology on high-resolution computed tomography in children with cystic fibrosis. Pediatr Pulmonol 2002;33:475-482.
9. Chang AB, Masel JP, Boyce NC, Wheaton G, Torzillo PJ. Non-CF bronchiectasis: Clinical and HRCT evaluation. Pediatr Pulmonol 2003;35:477-483.
10. Cole PJ. Inflammation: A two-edged sword-the model of bronchiectasis (abstract). Eur J Respir Dis (Suppl) 1986;147:6-15.
11. Tsang KW, Ho PL, Lam WK, Ip MS, Chan KN, Ho CS, Ooi CC, Yuen KY. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. Am J Respir Crit Care Med 1998;158:723-727.
12. Standardization of spirometry. 1994 update. American Thoracic Society. Am J Respir Crit Care Med 1995;152:1107-1136.
13. Polgar G, Promadhat V. Pulmonary function testing in children: Techniques and standards. Philadelphia: WB Saunders; 1971.
14. Wong HH, Fahy JV. Safety of one method of sputum induction in asthmatic subjects. Am J Respir Crit Care Med 1997;156:299-303.
15. Loukides S, Bouros D, Papatheodorou G, Lachanis S, Panagou P, Siafakas NM. Exhaled H(2)O(2) in steady-state bronchiectasis: Relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. Chest 2002;121: 81-87.
16. Ferris BG. Epidemiology standardization project. Am Rev Respir Dis 1978;118:1-120.
17. Sherman CB, Xu X, Speizer FE, Ferris BG, Jr., Weiss ST, Dockery DW. Longitudinal lung function decline in subjects with respiratory symptoms. Am Rev Respir Dis 1992;146:855-859.
18. Stockley RA, Bayley D, Hill SL, Hill AT, Crooks S, Campbell EJ. Assessment of airway neutrophils by sputum colour: Correlation with airways inflammation. Thorax 2001;56:366-372.
19. Ooi GC, Khong PL, Chan-Yeung M, Ho JC, MD, Chan PK, Lee JC, Lam WK, Tsang KW. High-resolution CT quantification of bronchiectasis: Clinical and functional correlation. Radiology 2002;225:663-672.
20. Loubeyre P, Paret M, Revel D, Wiesendanger T, Brune J. Thin-section CT detection of emphysema associated with bronchiectasis and correlation with pulmonary function tests. Chest 1996; 109:360-365.
21. Woolhouse IS, Bayley DL, Stockley RA. Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis. Thorax 2002; 57:667-671.
22. Karakoc F, Karadag B, Akbenlioglu C, Ersu R, Yildizeli B, Yuksel M, Dagli E. Foreign body aspiration: What is the outcome? Pediatr Pulmonol 2002;34:30-36.
23. Stillwell PC. Bronchiectasis. In: Gerald M Loughlin, Howard Eigen, editors. Respiratory diseases in children - diagnosis and management. Baltimore: Williams& Wilkins; 1994. pp 307-313.
24. Ellis DA, Thornley PE, Wightman AJ, Walker M, Chalmers J, Crofton JW. Present outlook in bronchiectasis: Clinical and social study and review of factors influencing prognosis. Thorax 1981; 36:659-664.
25. Kilinc MO, Ninis VN, Dagli E, Demirkol M, Ozkinay F, Arikan Z, Cogulu O, Huner G, Karakoc F, Tolun A. Highest heterogeneity for cystic fibrosis: 36 mutations account for 75% of all CF chromosomes in Turkish patients. Am J Med Genet 2002;113:250-257.
26. Brown MA, Lemen RJ. Bronchiectasis. In: Chernick V, Boat T, Kendig E, editors. Kendig's disorders of the respiratory tract in children. 6th edition. Philadelphia: W.B. Saunders Co; 1998. pp 538-552.
27. Field CE. Bronchiectasis in childhood. I. Clinical survey of 160 cases. Pediatrics 1949;4:21.
28. Dagli E. Non cystic fibrosis bronchiectasis. Paediatr Resp Rev 2000;1:64-70.
29. Orie NG. The relationship between asthma and chronic obstructive and restrictive pulmonary diseases; lessons from the past century. Ned Tijdschr Geneeskd 2002;146:1504-1508.
30. Murphy MB, Reen DJ, Fitzgerald MX. Atopy, immunological changes, and respiratory function in bronchiectasis. Thorax 1984;39:179-184.
31. Ferkol TW, Davis PB. Bronchiectasis and bronchiolitis obliterans. In: Taussig LM, Landau LI, Le Souef PN, Morgan WJ, Martinez FD, Sly PD, editors. Pediatric respiratory medicine. Missouri: Mosby Inc.; 1999. pp 784-792.
32. Munro NC, Cooke JC, Currie DC, Strickland B, Cole PJ. Comparison of thin section computed tomography with bronchography for identifying bronchiectatic segments in patients with chronic sputum production. Thorax 1990;45:135-139.
33. Li AM, Sonnappa S, Lex C, Wong E, Zacharasiewicz A, Bush A, Jaffe A. Non-CF bronchiectasis: Does knowing the aetiology lead to changes in management? Eur Respir J 2005;26:8-14.
34. Suri R, Marshall LJ, Wallis C, Metcalfe C, Shute JK, Bush A. Safety and use of sputum induction in children with cystic fibrosis. Pediatr Pulmonol 2003;35:309-313.
35. Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, Gleich GJ, Doloyich J, Hargreave FE. Indices of airway inflammation in induced sputum: Reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996;154:308-317.
36. Angrill J, Agusti C, De Celis R, Filella X, Rano A, Elena M, De La Bellacasa JP, Xaubet A, Torres A. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. Am J Respir Crit Care Med 2001;164:1628-1632.
37. Shum DK, Chan SC, Ip MS. Neutrophil-mediated degradation of lung proteoglycans: Stimulation by tumor necrosis factor-alpha in sputum of patients with bronchiectasis. Am J Respir Crit Care Med 2000;162:1925-1931.
38. Zhang X, Moilanen E, Kankaanranta H. Beclomethasone, budesonide and fluticasone propionate inhibit human neutrophil apoptosis. Eur J Pharmacol 2001;431:365-371.
39. Sepper R, Konttinen YT, Ding Y, Takagi M, Sorsa T. Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease. Chest 1995;107: 1641-1647.
40. Richman-Eisenstat JB, Jorens PG, Hebert CA, Ueki I, Nadel JA. Interleukin-8: An important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol 1993;264:L413-L418.
41. Zheng L, Shum H, Tipoe GL, Leung R, Lam WK, Ooi GC, Tsang KW. Macrophages, neutrophils and tumour necrosis factor-alpha expression in bronchiectatic airways in vivo. Respir Med 2001; 95:792-798.
42. Hill A, Gompertz S, Stockley R. Factors influencing airway inflammation in chronic obstructive pulmonary disease. Thorax 2000;55:970-977.
43. Elborn JS, Johnston B, Allen F, Clarke J, McGarry J, Varghese G. Inhaled steroids in patients with bronchiectasis. Respir Med 1992;86:121-124.
44. Tsang KW, Tan KC, Ho PL, Ooi GC, Ho JC, Mak J, Tipoe GL, Ko C, Yan C, Lam WK, Chan-Yeung M. Inhaled fluticasone in bronchiectasis: A 12 month study. Thorax 2005;60:239-243.
45. Martinez-Garcia MA, Perpina-Tordera M, Roman-Sanchez P, Soler-Cataluna JJ. Inhaled steroids improve quality of life in patients with steady-state bronchiectasis. Respir Med 2006;100: 1623-1632.